Summary Objectives: Disodium cromoglycate (DSCG) and nedocromil sodium are anti-asthma drugs that have a variety of physiological and biological effects. We examined whether DSCG affects the induction of cysteinyl leukotriene (cysLT) synthesis during dimethyl sulfoxide (DMSO)-induced granulocytic differentiation in HL-60 cells.
Introduction
Cromons, disodium cromoglycate (DSCG) and nedocromil sodium, are classified as anti-allergy drugs that are clinically effective for allergic diseases, including bronchial asthma. [1] [2] [3] [4] [5] [6] DSCG inhibits mediator releases from a wide range of cells 2, 5 and affects cell differentiation. [7] [8] [9] The human leukemia (HL)-60 is a cell line that can be used in an experimental model providing the possibility to examine the regulation of arachidonic acid (AA) metabolism in myeloid cells. HL-60 cells can be differentiated into morphologically mature granulocyte like cells, 10, 11 which produce a various kind of arachidonate metabolites including leukotrienes. Leukotriene (LT) B 4 and cysteinyl leukotrienes (cysLTs; LTC 4 , LTD 4 and LTE 4 ) are important chemical mediators of allergic diseases including bronchial asthma. Messenger RNA(mRNA) and enzyme activities for LT-synthetic enzymes and protein, such as cytosolic phospholipase A 2 (cPLA 2 ), five-lipoxygenase (5-LO), five-lipoxygenase activating protein (FLAP), LTA 4 hydrolase and LTC 4 synthase, is known to be induced during DMSO-initiated differentiation of HL-60 cells. [12] [13] [14] [15] [16] We examined whether DSCG affected the induction of LT-synthetic activities in the process of DMSO-initiated cell differentiation.
Materials and methods

Materials
HL-60 cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). Oligo (dT) primer, RNA guard, ethidium bromide and a 100 bp DNA ladder were obtained from Pharmacia (Uppsala, Sweden), RPMI 1640, antibiotic-antimyotic liquid (penicillin G, streptomycin, amphotericine B), fetal bovine serum, Moloney murine leukemia virus reverse transcriptase, dithiothreitol and 5 Â reaction buffer were from Gibco BRL (Grand Island, NY), deoxyribonucleoside triphosphate (dNTP) mixture, recombinant Taq DNA polymerase and 10 Â polymerase chain reaction (PCR) buffer from Takara Shuzo (Kyoto, Japan), and Isogen was from Nippon Gene Co. (Tokyo, Japan); A23187, glutathion (reduced form) and diethyl pyrocarbonate (DEPC) was obtained from Sigma Chemical Co. (St. Louis, MO). Agarose MS-12 was from Cosmo BIO (Tokyo, Japan). Hepes, Norit A, and EDTA were obtained from Wako (Osaka, Japan). LTB 4 , LTC 4 and TXB 2 were obtained from Funakoshi (Tokyo, Japan). We purchased [5, 6, 8, 9, 11, 12, 15 4 and TXB 2 were provided by Professor Daniel Tai (University of Kentucky, Lexington, KY). PCR primer pairs specific for beta-actin, cPLA 2 , 5-LO, FLAP, LTC 4 synthase and LTA 4 hydrolase were from Nippon Seifun (Tokyo, Japan). All other materials were special grade and purchased from commercial sources.
Methods
Culture and manipulation of HL-60 cells Cells were cultured in RPMI-1640 medium supplemented with an antibiotic-antimycotic solution (penicillin G 100 unit/ml, streptomycin 100 mg/ml, amphotericin B 0.25 mg/ml), 26 mM NaHCO 3 and 10% FBS at 371C under a 5% CO 2 atmosphere. Near confluent cells were seeded into polystyrene culture dishes at a density of 5 Â 10 5 cells/ml in 10 ml of RPMI-1640 with 10% FBS and incubated for 5 days with or without 1.5% (v/v) DMSO in the absence or presence of DSCG (0-100 mg/ml), ketotifen (0-10À 6 M), or pranlukast (0-10À 6 M) at 371C under a 5% CO 2 atmosphere. After incubation, the cells were collected and washed twice with phosphate buffered saline (PBS) before experiments. Cell viability was checked using Trypan blue stain. Differentiation of the cells was determined by morphological changes using May-GrunwaldGiemsa staining.
In a separate experiment, we conducted a timecourse study in order to clarify the time-dependent action of DSCG on LT-synthetic activity. DSCG was added into the medium on days 0, 1, 2, 3, 4 and 5 at 100 mg/ml (incubation periods with DSCG; 5, 4, 3, 2, 1 and 0 days, respectively). 4 , LTC 4 and TXB 2 synthesis After incubation with DMSO and DSCG as described above, the cells (5 Â 10 5 cells) were seeded into 24-well dishes in 1 ml of RPMI-1640 per well. The cells were stimulated with A23187 (10 À5 M) for 15 min at 371C, the medium was collected and then LTB 4 was measured using a radioimmunoassay (RIA), as previously described. 17 In brief, 100 ml of medium was incubated at 41C for 10 h with 100 ml each of anti-LTB 4 anti-serum, [ 3 H]-LTB 4 , and 50 mM sodium phosphate buffer (pH7.4) containing 0.9% NaCl and gamma-globulin (1 mg/ml). Free [ 3 H]-LTB 4 was separated by centrifugation at 3000 rpm for 10 min after adding of 0.5 ml of charcoal-coated gamma-globulin to the assay mixture. The supernatant was transferred to scintillation vials, and radioactivity was measured using a liquid scintillation counter (model LS 7500; Beckman, Irvine, CA). The amount of LTB 4 was calculated from a standard curve. The detectable range of LTB 4 was from 16 to 1000 pg/100 ml. RIA for LTC 4 4 . The detectable range of TXB 2 was from 16 to 1000 pg/100 ml.
Measurement of LTB
RNA extraction and RT-PCR Cells (5 Â 10 6 cells) were lysed after adding 1 ml of Isogen, then chloroform was added and the mixture was centrifuged. The aqueous (upper) phase was removed to another tube. Isopropanol was added and centrifuged. The supernatant was discarded, the pellet was resuspended in 75% ethanol and centrifuged. Total RNA extracted from the pellet was dissolved in 10 ml of DEPC-treated water and quantified by measuring the absorbance at 260 nm with a spectrometer (model DU-600; Beckman, Irvine, CA). Complementary DNA (cDNA) was synthesized from the reverse transcription mixture (final volume, 20 ml) containing 1 mg of total RNA, 1 mg of oligo (dT) primer, 4 ml of 5 Â reaction buffer, 2 ml of 0.25 M dithiothreitol, 4 ml of dNTP mixture (2.5 mM each), 1 ml of RNA guard (5 units), 1 ml of Moloney murine leukemia virus reverse transcriptase (200 units), and DEPC-treated water. PCR proceeded at a total volume of 50 ml containing 1 ml of the reverse transcription reaction products, 5 ml of 10 Â PCR buffer, 4 ml of dNTP mixture (2.5 mM each), 0.25 ml of Taq DNA polymerase (5 units/ml), 100 pmol of paired primers (cPLA 2 , 5-LO, FLAP, LTA 4 hydrolase, LTC 4 synthase or beta-actin), and 37.25 ml of DEPC-treated water. The DNA was amplified with each paired primer with 28 cycles of denaturation at 941C for 30 s, annealing at 561C for 30 s, and extension at 721C for 1 min. The primers were: cPLA 2 
0 TAGCAGGTGGCGTTT ACGAAG. The sizes of the PCR products were 580 bp for cPLA 2 , 488 bp for 5-LO, 116 bp for FLAP, 208 bp for LTA 4 hydrolase, 296 bp for LTC 4 synthase and 314 bp for beta-actin. Ten ml of each product was applied on agarose gel, separated by electrophoresis, visualized under UV light, photographed using the gel documentation system, Image Master VDS (Pharmacia Biotech Co., Tokyo, Japan), and semi-quantified as described. 17 Measurement of LTA 4 hydrolase-and LTC 4 synthase activities The cells were washed twice with 10 ml of HEPES buffer (137 mM NaCl, 2.6 mM KCl, 0.36 mM NaH 2-PO 4 , 10 mM HEPES and 1 mM EDTA at pH 7.5) containing 1 mM dithothreitol, and resuspended in the same buffer at a concentration of 10 8 cells/ml. The cells were sonicated three times on ice (model W-225R, Heat Systems-Ultrasonics, Inc., Plainview, NY). The activities of LTA 4 hydrolase and LTC 4 synthase in the lysates were measured. LTA 4 methylester was saponified in 95% ethanol in 0.2 N NaOH for 30 min to produce LTA 4 free acid. LTA 4 free acid was diluted with 20 ml of HEPES buffer containing 10 mg/ml bovine albumin (LTA 4 solution, at pH 11.5-12.1) and used within 30 min as the substrate. A mixture of cell lysates and GSH (180 ml) was incubated for 1 min at 371C, then 20 ml of the LTA 4 solution was added, and the mixture was incubated for a further 5 min at 371C. The reaction was stopped by adding 2 ml of methanol. The production of LTB 4 and LTC 4 was measured using high performance liquid chromatography (HPLC) as described. 17 In brief, the samples were partially purified, concentrated by passing through a Sep Pak C18 cartridge (Waters, Milford, MA) and applied to HPLC system (TOSO, model 8010, Tokyo, Japan) equipped with a Novapak C18 column (Waters, Milford, MA). The samples were eluted with acetonitrile:methanol:water:acetic acid [31:17.68: 51.24:0.68 (v/v)] at 0.8 ml/min and the absorbance was monitored using a spectrophotometer at 280 nm. The concentration of LTs was normalized by the protein concentration determined by the Lowry method.
Statistical analysis
The data are shown as means7SEM. The data were statistically analyzed by one-way analysis of variance. A P-value of o0.05 was defined as statistically significant.
Results
Morphological effect of DSCG on DMSOinduced granulocytic differentiation of HL-60 cells Fig. 1 shows that the ratio (%) of differentiated cells was significantly increased by DMSO treatment, when compared with that of the untreated cells. DSCG had no effect on morphological change in granulocytic differentiation in HL-60 cells. Neither ketotifen, an oral anti-allergic drug, nor pranlukast, a cysLT1 receptor antagonist, changed the ratio of differentiated cells (data not shown).
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Effect of DSCG on LTC 4 -, LTB 4 -and TXB 2 -synthesis during DMSO-induced granulocytic differentiation of HL-60 cells Table 1 shows that the production of LTC 4 , LTB 4 and TXB 2 in DMSO-differentiated cells was significantly increased, when compared to that in untreated cells. The production of LTC 4 was significantly suppressed by DSCG. The production of LTB 4 and TXB 2 was also decreased in accordance with an increasing DSCG dose. After HL-60 cells were differentiated by exposure to DMSO without DSCG for 5 days, production of LTC 4 , LTB 4 and TXB 2 was not influenced by DSCG at 1-100 mg/ml; incubation periods for 1-12 h (data not shown).
The production of LTC 4 , LTB 4 and TXB 2 in DMSOtreated cells tended to be decreased by ketotifen and pranlukast, but it was not significant ( Table 1) .
Effect of DSCG on mRNA expression for cPLA 2 , 5-LO, FLAP, LTC 4 synthase and LTA 4 hydrolase during DMSO-induced granulocytic differentiation of HL-60 cells
The expression of the mRNA for cPLA 2 , 5-LO, FLAP, LTC 4 synthase, LTA 4 hydrolase, and beta-actin in DMSO-induced HL-60 cells is shown in Fig. 2A . The densitometric analysis of the PCR products is demonstrated in Fig. 2B . The abundance of mRNA for 5LO, LTC 4 synthase and LTA 4 hydrolase in DMSOdifferentiated cells was significantly increased, when compared to that of untreated cells. The abundance of cPLA 2 mRNA was decreased, whereas the abundance of mRNA for FLAP and beta-actin was not changed by the treatment of DMSO. The DMSO-induced enhancement of mRNA for LTC 4 synthase was dose-dependently inhibited by DSCG. The mRNA expression for cPLA 2 , 5-LO, FLAP, LTA 4 hydrolase was not changed by DSCG.
Effect of DSCG on the induction of LTC 4 synthase-and LTA 4 hydrolase activities during DMSO-induced granulocytic differentiation of HL-60 cells Time course study for the effect of DSCG on LTC 4 
synthesis during DMSO-induced granulocytic differentiation of HL-60 cells
As shown in Fig. 4 , induction of LTC 4 synthetic activity was suppressed when DSCG was added into the medium within 48 h after DMSO treatment. 
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Discussion
This study demonstrated that DSCG inhibited DMSOinduced LTC 4 synthesis and mRNA expression for LTC 4 synthase during granulocytic differentiation of HL-60 cells. Other investigators previously reported that DSCG inhibited the synthesis of cysLTs. 2, [18] [19] [20] [21] [22] However, these studies did not examine the mRNA expression of LT-synthetic enzymes such as cPLA 2 , 5-LO, FLAP, LTA 4 hydrolase and LTC 4 synthase. Among these LT-synthetic enzymes, LTC 4 synthase is a key enzyme for cysLT synthesis, and it may be an important target for asthma treatment. In this study we demonstrated that DSCG suppressed LTC 4 synthesis, an initial product of cysLTs, by inhibiting the induction of mRNA for LTC 4 synthase during granulocytic differentiation of HL-60 cells. These results indicate a novel anti-allergic mechanism of DSCG. Several weeks may be necessary before the effects of DSCG appear in patients with asthma. Our results may explain this time lag of the appearance of clinical efficacy and the initiation of the drug. Marquardt et al. reported that longterm exposure to cromolyn inhibited LTC 4 generation in mouse mast cells, 22 although they did not mention the effect of DSCG on LTC 4 synthase activity in these cells. DSCG may affect induction of the LT-synthetic enzymes during differentiation or maturation in other inflammatory cell types including mast cell, although there is no definite evidence.
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In this study, a higher dose of DSCG inhibited DMSO-induced LTB 4 -and TXB 2 -synthetic activities. This mechanism could not be explained from our study. DSCG did not reduce mRNA expression for cPLA 2 , 5-LO, FLAP, LTA 4 hydrolase or cyclooxygenases (data not shown). A previous study demonstrated that DSCG stabilized the membrane 2, 5, 19 and eliminated voltage-dependent Ca 2 þ currents. 23 A higher dose of DSCG may affect the regulation of Ca 2 þ influx and lead to the inhibition of AA metabolism in HL-60 cells. The synthesis of LTs and TX is initiated by transmembranous stimulation via various factors that increase the Ca 2 þ influx, leading to cPLA 2 activation. It is possible that the activity of cPLA 2 , a common pivotal enzyme for production of cyclooxygenase-and 5-lipoxygenase-metabolism, is inhibited due to the suppression of Ca 2 þ influx by high doses of DSCG. In conclusion, we have demonstrated that DSCG suppressed cysLT synthesis during DMSO-induced granulocytic differentiation in HL-60 cells. These actions may be clinically relevant to the effect of DSCG, although the inhibition by DSCG is modest our data might not correctly reflect the inhibitory effect of DSCG on cysLT synthesis in vivo. Figure 4 Time course study of DSCG on LTC 4 synthesis during DMSO-induced granulocytic differentiation of HL-60 cells. Cells were incubated with DMSO for 5 days. DSCG (100 mg/ml) was added into the medium and incubated for various periods of time (0-5 days) before A23187 challenge. A23187stimulated LTC 4 production was measured by RIA as described in the Materials and methods. Data represent means7SEM.
Ã Po0:05 vs. cells with DMSO and without DSCG. DMSO, dimethyl sulfoxide; DSCG, disodium cromoglycate.
